mecamylamine has been researched along with Epilepsy, Tonic-Clonic in 2 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Epilepsy, Tonic-Clonic: A generalized seizure disorder characterized by recurrent major motor seizures. The initial brief tonic phase is marked by trunk flexion followed by diffuse extension of the trunk and extremities. The clonic phase features rhythmic flexor contractions of the trunk and limbs, pupillary dilation, elevations of blood pressure and pulse, urinary incontinence, and tongue biting. This is followed by a profound state of depressed consciousness (post-ictal state) which gradually improves over minutes to hours. The disorder may be cryptogenic, familial, or symptomatic (caused by an identified disease process). (From Adams et al., Principles of Neurology, 6th ed, p329)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Oliveira, RC | 2 |
de Oliveira, R | 2 |
Biagioni, AF | 1 |
Falconi-Sobrinho, LL | 1 |
Coimbra, NC | 2 |
Zanandréa, PC | 1 |
Paschoalin-Maurin, T | 1 |
2 other studies available for mecamylamine and Epilepsy, Tonic-Clonic
Article | Year |
---|---|
Dorsal raphe nucleus acetylcholine-mediated neurotransmission modulates post-ictal antinociception: The role of muscarinic and nicotinic cholinergic receptors.
Topics: Acetylcholine; Analgesics; Animals; Atropine; Dorsal Raphe Nucleus; Epilepsy, Tonic-Clonic; GABAergi | 2016 |
Acetylcholine-mediated neurotransmission within the nucleus raphe magnus exerts a key role in the organization of both interictal and postictal antinociception.
Topics: Acetylcholine; Animals; Atropine; Cholinergic Agonists; Cholinergic Antagonists; Disease Models, Ani | 2011 |